Uroporphyrinogen decarboxylase (URO-D) catalyzes the fifth step in the
heme biosynthetic pathway, converting uroporphyrinogen to coproporphy
rinogen by decarboxylating the four acetate side chains of the substra
te. This activity is essential in all organisms, and subnormal activit
y of URO-D leads to the most common form of porphyria in humans, porph
yria cutanea tarda (PCT), We have determined the crystal structure of
recombinant human URO-D at 1.60 Angstrom resolution, The 40.8 kDa prot
ein is comprised of a single domain containing a (beta/alpha)(8)-barre
l with a deep active site cleft formed by loops at the C-terminal ends
of the barrel strands. Many conserved residues cluster at this cleft,
including the invariant side chains of Arg37, Arg41 and His339, which
probably function in substrate binding, and Asp86, Tyr164 and Ser219,
which may function in either binding or catalysis, URO-D is a dimer i
n solution (K-d = 0.1 mu M), and this dimer also appears to be formed
in the crystal. Assembly of the dimer juxtaposes the active site cleft
s of the monomers, suggesting a functionally important interaction bet
ween the catalytic centers.